JP3353945B2 - Coated carrier - Google Patents

Coated carrier

Info

Publication number
JP3353945B2
JP3353945B2 JP11426893A JP11426893A JP3353945B2 JP 3353945 B2 JP3353945 B2 JP 3353945B2 JP 11426893 A JP11426893 A JP 11426893A JP 11426893 A JP11426893 A JP 11426893A JP 3353945 B2 JP3353945 B2 JP 3353945B2
Authority
JP
Japan
Prior art keywords
coated carrier
coating layer
adsorbent
less
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP11426893A
Other languages
Japanese (ja)
Other versions
JPH06296859A (en
Inventor
一 吉田
徳生 稲摩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Medical Co Ltd filed Critical Asahi Medical Co Ltd
Priority to JP11426893A priority Critical patent/JP3353945B2/en
Publication of JPH06296859A publication Critical patent/JPH06296859A/en
Application granted granted Critical
Publication of JP3353945B2 publication Critical patent/JP3353945B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】溶液、特に体液中の成分を吸着す
るために吸着材が用いられている。本発明は、この吸着
材に有用な多孔質担体に関する。
BACKGROUND OF THE INVENTION Adsorbents are used to adsorb components in solutions, especially body fluids. The present invention relates to a porous carrier useful for the adsorbent.

【0002】[0002]

【従来の技術】溶液中に溶解した物質を吸着するため
に、該物質と親和性のある分子を、多孔質の担体表面に
不溶化した吸着材が、医療、工業等の分野や、分析など
の基礎研究の分野で広く利用されている。この多孔質担
体には、セルロースやデキストラン、キトサン、スチレ
ン・ジビニルベンゼンなどの素材からなる球状あるいは
ビーズ状の多孔質担体が多く利用されている。特に医学
の分野では、病因物質と選択的に結合する分子、即ちリ
ガンドを多孔質の多孔質担体に有する吸着材を用いて、
体外に取り出した患者の血液或いは血漿などの体液を吸
着材と接触させ、血液中の病因物質を吸着除去した後再
度患者に戻す治療法、例えば体外循環治療等で利用され
ている。例えば、セルロース製のビーズ状多孔質担体に
デキストラン硫酸を共有結合したもの、ポリビニルアル
コール製のビーズ状多孔質担体にトリプトファンを共有
結合したもの等である。これらビーズ状の多孔質担体は
細密充填が難しく、プライミングボリュームが大きいな
どの問題点があった。この問題点を解決する目的で、繊
維状の多孔質吸着材が知られている(特開昭60−24
6765)。該発明に示された繊維状の多孔質吸着材
は、上記ビーズ状担体を用いた吸着材の問題点を解決し
たものであったが、本発明者らの研究によると、多孔質
ガラス繊維等の該発明の多孔質担体は脂質や蛋白質など
の非特異吸着が多く、リガンドを表面に固定して選択的
或いは特異的吸着材としての使用には不適であった。更
に表面への官能基の導入が困難で、導入できる官能基の
種類も限られるため汎用性がなく、よってリガンドを安
定に固定する担体として問題があった。また、吸着材単
位容積当たりの被吸着物質の吸着量、即ち吸着性能は多
孔質支持体が被吸着物質の接触・吸着可能な表面積を如
何に多く有しているかによって決まる。該表面積は吸着
材担体の外部表面積と内部表面積の和であるが、従来ビ
ーズ状担体では内部表面積を大きくする目的で孔径を大
きくする、或いは孔数を増やすなどが成されているが、
ビーズ状担体で得られる孔は本発明とは異なり実質的に
は貫通せず、表面から内部にいくにつれ小さくなるので
孔内に吸着した被吸着物質によって封鎖され、それ以上
の被吸着物質を含む体液は流入できない或いは、内部に
入り込む被吸着物質を含む体液は拡散によるもので限度
がある、等の問題点があった。また、外部表面積を大き
くする目的でビーズ状担体の粒子径を小さくすると通液
抵抗が大となり、さらには粒子がカラム外へ流出する恐
れもあり危険である。つまり有効に使うことができる表
面積の増大には限度があった。
2. Description of the Related Art In order to adsorb a substance dissolved in a solution, an adsorbent obtained by insolubilizing a molecule having an affinity for the substance on the surface of a porous carrier is used in fields such as medical and industrial fields and analysis. Widely used in the field of basic research. As the porous carrier, a spherical or bead-shaped porous carrier made of a material such as cellulose, dextran, chitosan, and styrene / divinylbenzene is often used. Particularly in the field of medicine, using an adsorbent having a molecule that selectively binds to a pathogen, that is, a ligand on a porous carrier,
It is used in a treatment method in which a bodily fluid such as blood or plasma of a patient taken out of the body is brought into contact with an adsorbent, and a pathogenic substance in the blood is adsorbed and removed and returned to the patient again, for example, extracorporeal circulation treatment or the like. For example, those obtained by covalently binding dextran sulfate to a bead-shaped porous carrier made of cellulose, those obtained by covalently binding tryptophan to a bead-shaped porous carrier made of polyvinyl alcohol, and the like. These bead-shaped porous carriers have problems such as difficulty in close packing and a large priming volume. For the purpose of solving this problem, a fibrous porous adsorbent is known (JP-A-60-24).
6765). Although the fibrous porous adsorbent disclosed in the present invention has solved the problems of the adsorbent using the above-described bead-shaped carrier, according to the study of the present inventors, it has been found that porous glass fibers and the like The porous carrier of the invention has many non-specific adsorptions of lipids and proteins, and is not suitable for use as a selective or specific adsorbent by immobilizing a ligand on the surface. Furthermore, it is difficult to introduce a functional group into the surface, and the types of functional groups that can be introduced are limited, so there is no versatility, and thus there is a problem as a carrier for stably fixing a ligand. Further, the amount of adsorbed substance per unit volume of adsorbent, that is, the adsorption performance is determined by how much the porous support has a surface area capable of contacting and adsorbing the adsorbed substance. Although the surface area is the sum of the external surface area and the internal surface area of the adsorbent carrier, in the conventional bead-shaped carrier, the pore size is increased for the purpose of increasing the internal surface area, or the number of pores is increased.
Unlike the present invention, the pores obtained from the bead-shaped carrier do not substantially penetrate, and become smaller from the surface to the inside, so that they are blocked by the substance to be adsorbed adsorbed in the pores and contain more substances to be adsorbed. There is a problem that the bodily fluid cannot flow in or the bodily fluid containing the substance to be adsorbed which enters into the inside is limited by diffusion and is limited. Further, if the particle diameter of the bead-shaped carrier is reduced for the purpose of increasing the external surface area, the flow resistance increases, and furthermore, there is a danger that particles may flow out of the column. That is, there is a limit to the increase in the surface area that can be used effectively.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的は、脂質
や蛋白質の非特異吸着がなく、血液などの体液との適合
性に優れ、多くのリガンドを容易且つ安定に固定でき、
吸着能力に優れた吸着材用の被覆担体を提供するにあ
る。
SUMMARY OF THE INVENTION An object of the present invention is to provide non-specific adsorption of lipids and proteins, excellent compatibility with body fluids such as blood, and easy and stable immobilization of many ligands.
An object of the present invention is to provide a coated carrier for an adsorbent having excellent adsorption ability.

【0004】[0004]

【課題を解決するための手段】本発明の要旨は下記のと
おりのものである。有機合成高分子材料からなる吸着材
用の中実繊維状多孔質担体の表面に高分子被覆層を有す
被覆担体であって、該中実繊維状多孔質担体の細孔形
状が貫通孔であることを特徴とする被覆担体。以下に、
本発明を項目別に説明する。
The gist of the present invention is as follows. On the surface of the actual fiber 維状 porous carrier in the adsorbent for made of an organic synthetic polymer material a coated carrier having a polymer coating layer, the pore shape of the middle actual fibrous porous carrier
A coated carrier having a shape of a through hole . less than,
The present invention will be described item by item.

【0005】内部表面積の定義 多孔質担体内の全孔の表面積の総和を言う。Definition of internal surface area The total surface area of all pores in a porous carrier.

【0006】被覆担体の定義 本発明でいう被覆担体とは、目的とする物質と親和性の
ある分子、即ちリガンドを表面に不溶化することによっ
て吸着材とするための、表面に開孔した多くの細孔を有
する多孔質の担体であって、太さに対して長手方向の長
さが十分に長い、糸状或いは繊維状の中実繊維膜状多孔
質支持体表面を親水性材料で被覆処理した物を言う。被
覆担体は、断面の形状が円、楕円、多角形状、星形等い
ずれの形状であっても良い。更に断面中央部に、長手方
向に沿って実質的に同一形状で貫通した孔を有さない。
ここで言う断面中央部に、長手方向に沿って実質的に同
一形状で貫通した孔とは、中空糸膜が有する、例えば紡
糸時に連続的に形成される、中空糸外部と膜で隔てられ
た内部空間等を指し、細孔の連続によって不規則に形成
されたものをいわない。
Definition of coated carrier The coated carrier as used in the present invention refers to a large number of pores formed on the surface for insolubilizing a molecule having an affinity for a target substance, that is, a ligand, on the surface to make it an adsorbent. A porous support having pores, the length of which is sufficiently long in the longitudinal direction with respect to the thickness. The surface of a fibrous or fibrous solid fiber membrane-like porous support is coated with a hydrophilic material. Say things. The cross-section of the coated carrier may be any shape such as a circle, an ellipse, a polygon, and a star. Furthermore, there is no hole penetrating substantially in the same shape along the longitudinal direction in the center of the cross section.
At the center of the cross section, a hole penetrating in substantially the same shape along the longitudinal direction is separated from the outside of the hollow fiber by the hollow fiber membrane, for example, which is formed continuously during spinning. Refers to an internal space or the like, and does not refer to anything that is irregularly formed by continuation of pores.

【0007】親水性被覆層の定義 本発明でいう親水性被覆層とは、水溶液や血液との親和
性をよくするために、中実繊維膜状多孔質支持体を実質
的に覆う親水性の重合体であって、接触角測定法によっ
て求められる平板状にした時の表面の水滴の接触角が8
0度以下であるものが好ましく、重合体を重合体単位の
単量体としての名前で例示すれば、ヒドロキシスチレ
ン、ヒドロキシメチルスチレン、ビニルアルコール、2
−ヒドロキシエチルアクリレート、2−ヒドロキシエチ
ルメタクリレート、ビニルアミン、ジエチルアミノエチ
ルスチレン、ジエチルアミノエチルメタクリレート、メ
トキシトリエチレングリコールメタクリレート、ジメチ
ルアミノエチル(メタ)アクリレートセグメント化ポリ
ウレタン、セグメント化ポリエステル等のブロック共重
合体、ポリエチレンオキサイド鎖を有する単量体と他の
重合単量体のようなグラフト共重合体、エチレン−ビニ
ルアルコール、ポリエステル、ポリエチレングリコー
ル、等が例示できる。
Definition of hydrophilic coating layer The hydrophilic coating layer referred to in the present invention is a hydrophilic coating that substantially covers a solid fiber membrane-like porous support in order to improve the affinity with an aqueous solution or blood. It is a polymer, and the contact angle of water droplets on the surface when it is formed into a flat plate determined by a contact angle measurement method is 8
It is preferably 0 ° or less, and when a polymer is exemplified by a monomer as a polymer unit, hydroxystyrene, hydroxymethylstyrene, vinyl alcohol,
-Hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, vinylamine, diethylaminoethylstyrene, diethylaminoethyl methacrylate, methoxytriethylene glycol methacrylate, dimethylaminoethyl (meth) acrylate segmented polyurethane, block copolymer such as segmented polyester, polyethylene oxide Examples thereof include a graft copolymer such as a monomer having a chain and another polymerizable monomer, ethylene-vinyl alcohol, polyester, and polyethylene glycol.

【0008】特に重合体中にヒドロキシル基を有してい
ることが好ましい。ヒドロキシル基の重合体中における
結合様式に特に制限はない。これらの重合体の内、エチ
レン−ビニルアルコール、ポリエチレングリコール、メ
トキシトリエチレングリコールメタクリレートが親水性
の効果の点で好ましく、特にエチレン−ビニルアルコー
ルが塩基性官能基の導入に際して活性基を導入し易く、
且つ塩基性官能基導入時に剥離による親水性の低下が少
ないためより好ましい。親水性被覆層は、上記重合体単
位の単独重合体であってもよく、或いは2つ以上の共重
合体であっても良く、線状重合体、グラフト重合体、架
橋重合体などの重合形態には特に関係はない。
It is particularly preferred that the polymer has a hydroxyl group. There is no particular limitation on the mode of bonding of the hydroxyl groups in the polymer. Among these polymers, ethylene-vinyl alcohol, polyethylene glycol, and methoxytriethylene glycol methacrylate are preferred in terms of the hydrophilic effect, and particularly, ethylene-vinyl alcohol is easy to introduce an active group upon introduction of a basic functional group,
In addition, it is more preferable because the decrease in hydrophilicity due to peeling when introducing a basic functional group is small. The hydrophilic coating layer may be a homopolymer of the above polymer units, or may be a copolymer of two or more thereof, and may be a polymer form such as a linear polymer, a graft polymer, or a cross-linked polymer. Has nothing to do with it.

【0009】被覆層を得る方法 多孔質支持体に親水性被覆層を得る方法には、被覆層を
形成する化合物を溶解した液中に多孔質支持体を浸漬、
或いは該液を噴霧することによってコーティングする方
法、放射線や電子線を用いたグラフト法により多孔質支
持体表面に共有結合する方法、或いは化学的方法により
多孔質支持体表面の官能基を介して共有結合する方法な
どがある。この中で特にコーティングする方法が工業的
に容易に行なえ、有利である。ここで言うコーティング
法は、被覆層を形成する化合物中に重合性化合物も共存
させ、コーティング後に架橋させるものであってもよ
い。こうして得られた被覆層の量、即ち被覆量は、被覆
担体表面積あたりの被覆層の重量で現す時、10-5g/
2 以上で且つ1g/m2 以下である。被覆量が10-5
g/m2 未満では親水化が不十分で、親水性被覆層とし
ての効果が得られず、又、被覆量が1g/m2 を超える
と支持体の細孔を詰まらせ、多孔質担体として使用でき
なくなってしまうため、好ましくない。この被覆層の特
に好ましい量は10-4g/m2 以上10-1g/m2 以下
である。
Method for Obtaining Coating Layer A method for obtaining a hydrophilic coating layer on a porous support includes immersing the porous support in a solution in which a compound for forming the coating layer is dissolved.
Alternatively, a method of coating by spraying the liquid, a method of covalently bonding to the surface of the porous support by a grafting method using radiation or an electron beam, or a method of sharing via a functional group on the surface of the porous support by a chemical method There is a method of joining. Among them, the method of coating is particularly industrially easy and advantageous. The coating method referred to here may be a method in which a polymerizable compound is also present in a compound forming a coating layer, and crosslinking is performed after coating. The amount of the coating layer thus obtained, that is, the amount of coating, is expressed in terms of the weight of the coating layer per surface area of the coated carrier, 10 −5 g /
m 2 or more and 1 g / m 2 or less. 10 -5 coverage
When the amount is less than g / m 2 , the hydrophilicity is insufficient, and the effect as a hydrophilic coating layer cannot be obtained. When the amount exceeds 1 g / m 2 , the pores of the support are clogged, and as a porous carrier, It is not preferable because it cannot be used. A particularly preferred amount of this coating layer is from 10 -4 g / m 2 to 10 -1 g / m 2 .

【0010】孔径 被覆担体の細孔径と細孔容積は水銀圧入法により水銀圧
曲線から得られる。ここで言う細孔は、できるだけ実用
時に近い状態での値であることが良く、吸着材としての
使用形態時の値をいう。又、水銀圧入法での測定時の乾
燥処理によって形状が変わる場合は、被覆担体径の変化
を測定し、表面積は被覆担体径の変化率の2乗、細孔容
積は被覆担体径の3乗倍して補正することとした。即ち
被覆担体径が1/X倍となった時、表面積は1/X2
倍、細孔容積は1/X3 倍となったとする。被覆担体の
平均孔径は、細孔を円筒形であると仮定して全細孔体積
を細孔全表面積によって割り算することによって求めら
れる。この平均孔径はいずれであっても用いることがで
きるが、0.01μm未満では被吸着物質が被覆担体の
内部にまで十分に侵入せず、十分な吸着能力が得られ
ず、又10μmを超えると、強度が下がって変形し易く
なる危険性が増加し、又、おそらく全表面積が小さくな
りやはり十分な吸着能力は得られず、実用上好ましくな
い。好ましい平均孔径は0.01μm以上で且つ10μ
m以下である。0.05μm以上であることが好まし
く、特に0.1μm以上であることが最も好ましい。更
に5μm以下であることがより好ましく、特に2μm以
下であることが最も好ましい。
Pore size The pore size and pore volume of the coated carrier can be obtained from a mercury pressure curve by a mercury porosimetry. The pores mentioned here are preferably values in a state close to practical use as much as possible, and refer to values in a usage form as an adsorbent. When the shape changes due to the drying process at the time of measurement by the mercury intrusion method, the change in the diameter of the coated carrier is measured, and the surface area is the square of the rate of change in the diameter of the coated carrier, and the pore volume is the cube of the diameter of the coated carrier. It was decided to multiply and correct. That is, when the diameter of the coated carrier is 1 / X times, the surface area is 1 / X 2
And the pore volume is 1 / X 3 times. The average pore size of the coated carrier is determined by dividing the total pore volume by the total pore surface area, assuming that the pores are cylindrical. Any average pore diameter can be used, but if the average pore diameter is less than 0.01 μm, the substance to be adsorbed does not penetrate sufficiently into the interior of the coated carrier, and a sufficient adsorption capacity cannot be obtained. In addition, the danger of being easily deformed due to a decrease in strength is increased, and the total surface area is likely to be small, so that sufficient adsorption capacity cannot be obtained, which is not practically preferable. Preferred average pore size is 0.01 μm or more and 10 μm
m or less. It is preferably at least 0.05 μm, and most preferably at least 0.1 μm. It is more preferably 5 μm or less, and most preferably 2 μm or less.

【0011】孔形状 細孔は円形、楕円形、短冊形、星形、多角形、不定形、
その他いずれの形状であっても良いが、円形、楕円形、
短冊形であることが、被覆担体内部への被吸着物質の進
入のしやすさの点でより好ましい。更に、いずれの細孔
形状であっても貫通孔であることが、リガンドを支持体
内部にまで均一に不溶化でき、しかも被吸着物質が吸着
材内部にまで容易に進入できるため、非常に好ましい。
Pore shape The pores are circular, elliptical, strip-shaped, star-shaped, polygonal, irregular,
Any other shape may be used, such as circular, elliptical,
The strip shape is more preferable in terms of easy entry of the substance to be adsorbed into the inside of the coated carrier. Further, it is very preferable that the through-holes are used regardless of the pore shape, because the ligand can be uniformly insolubilized into the support and the substance to be adsorbed can easily enter the adsorbent.

【0012】孔径分布 孔径は、本発明の被覆担体では繊維表面から中心部まで
より均質な孔を得られて、内部まで有効に吸着に利用し
易いため、ビーズ状多孔質担体の様にブロードな孔径分
布にして内部まで有効に利用しようとする試みは特に重
要でない。被覆担体ではシャープな孔径分布にすること
が、有効表面積を吸着材単位容積当たりより多く確保で
きるためより好ましい。このため0.01μm以上10
μm以下の孔径の容積が全細孔容積の40%以上である
ことが好ましく、70%以上の時より好ましい。更には
0.05μm以上5μm以下の孔径の容積が全容積の4
0%以上であることがより好ましい。70%以上の時更
に好ましく、特に80%という非常にシャープな分布で
あることが最も好ましい。
Pore size distribution The pore size of the coated carrier of the present invention is broad as in the case of a bead-shaped porous carrier because more uniform pores can be obtained from the fiber surface to the center and can be effectively used for internal adsorption. Attempts to make the pore size distribution and use it effectively inside are not particularly important. It is more preferable that the coated carrier has a sharp pore size distribution because a larger effective surface area can be secured per unit volume of the adsorbent. Therefore, 0.01 μm or more
The volume of the pore size of μm or less is preferably 40% or more of the total pore volume, more preferably 70% or more. Furthermore, the volume of the pore diameter of 0.05 μm or more and 5 μm or less is 4% of the total volume.
More preferably, it is 0% or more. More preferably, it is 70% or more, and most preferably, it has a very sharp distribution of 80%.

【0013】全表面積 本発明の被覆担体の乾燥重量に対する全表面積は、特に
1m2 /g以上であることが好ましく、より好ましくは
5m2 /g以上であり、更に好ましくは10m2 /g以
上である。全表面積は大きければ大きいほど吸着能力は
高くなるのは自明であるが、体外循環治療用の吸着材の
多孔質支持体とし用いる場合は、全表面積が大きくなり
過ぎると吸着目的物質以外の物質の非特異吸着も又増加
する危険性が高くなる。特に血液や体液に対して使用す
る場合は共存する有用な微量蛋白質も多く、これらの非
特異吸着量が増加することは好ましくない。よって50
0m2 /g以下であることが好ましく、より好ましくは
300m2 /g以下であり、最も好ましくは150m2
/g以下である。
Total Surface Area The total surface area based on the dry weight of the coated carrier of the present invention is preferably at least 1 m 2 / g, more preferably at least 5 m 2 / g, even more preferably at least 10 m 2 / g. is there. It is obvious that the larger the total surface area is, the higher the adsorption capacity becomes.However, when used as a porous support of an adsorbent for extracorporeal circulation treatment, if the total surface area is too large, substances other than the target substance for adsorption will be removed. The risk of non-specific adsorption also increasing. In particular, when used for blood or body fluid, there are many useful trace proteins that coexist, and it is not preferable that the amount of nonspecific adsorption increases. Therefore 50
Is preferably 0 m 2 / g or less, and more preferably not more than 300 meters 2 / g, most preferably 150 meters 2
/ G or less.

【0014】孔径、孔径分布、表面積の測定方法 細孔径及び細孔分布は水銀圧入法により、水銀圧入曲線
によって求めることが出来る。また表面積は窒素などの
ガスを用いて、その吸着量より求める事も出来るが、
(BET法)細孔分布と対比した表面積が得られるた
め、細孔径と同様に水銀圧入法によって求める事が好ま
しい。具体的な孔径、孔径分布、表面積の測定は、水銀
ポロシメーター(島津製作所製、マイクロメリティック
ス・ポアサイズ9320)を用いて測定できる。測定結
果はポアプロットシステム(島津製作所社製、9320
−PC2(V1.0))にて分析し、孔径、孔径分布、
表面積を求めることが出来る。この時水銀の圧力範囲は
1〜30,000psiaとした。
Method for Measuring Pore Size, Pore Size Distribution, and Surface Area Pore size and pore distribution can be determined by a mercury intrusion method and a mercury intrusion curve. The surface area can also be determined from the amount of adsorption using a gas such as nitrogen,
(BET method) Since a surface area in comparison with the pore distribution is obtained, it is preferable to determine the surface area by the mercury intrusion method in the same manner as the pore diameter. The specific measurement of the pore size, pore size distribution, and surface area can be performed using a mercury porosimeter (Micromeritics pore size 9320, manufactured by Shimadzu Corporation). The measurement results were obtained using a pore plot system (manufactured by Shimadzu Corporation, 9320).
-PC2 (V1.0)), and the pore size, pore size distribution,
The surface area can be determined. At this time, the pressure range of the mercury was 1 to 30,000 psia.

【0015】細孔容積 被覆担体の全細孔容積は、被覆担体の乾燥重量あたりの
細孔容積の総量で示すと、0.1ml/g以上で且つ5
0ml/g以下であることが好ましい。全細孔容積が
0.1ml/g未満では、実用上有効に働く表面積が少
なくなってしまうため十分な吸着能力が得られない。又
全細孔容積が50ml/gを超えると被覆担体の強度が
低くなり、使用上好ましくない。更に被覆担体の全細孔
容積のより好ましい範囲を示すと、0.5ml/g以上
30ml/g以下であり、より好ましくは1ml/g以
上10ml/g以下である。
Pore Volume The total pore volume of the coated carrier is 0.1 ml / g or more and 5% or more in terms of the total pore volume per dry weight of the coated carrier.
It is preferably at most 0 ml / g. If the total pore volume is less than 0.1 ml / g, the surface area that works effectively for practical use is reduced, so that sufficient adsorption capacity cannot be obtained. On the other hand, if the total pore volume exceeds 50 ml / g, the strength of the coated carrier is lowered, which is not preferable for use. Further, the more preferable range of the total pore volume of the coated carrier is from 0.5 ml / g to 30 ml / g, more preferably from 1 ml / g to 10 ml / g.

【0016】担体の形状 被覆担体の長手方向の長さは、太さ、即ち径に対して実
質的に長ければ良く特に規定は不要であるが、取扱い性
の点で50mm以上であることが好ましい。径は、細過
ぎると被覆担体が切れ易く取扱い性が悪くなり、太過ぎ
るとおそらく被吸着物質が被覆担体内部に浸入しにくく
なるために吸着能力が低くなってしまうため、断面積を
円に換算した時の直径で1μm以上10mm以下が好ま
しく、10μm以上1mm以下が更に好ましい。特によ
り好ましくは50μm以上300μm以下である。
Shape of Carrier The length of the coated carrier in the longitudinal direction is not particularly limited as long as it is substantially longer than the thickness, that is, the diameter, but is preferably 50 mm or more from the viewpoint of handleability. . If the diameter is too small, the coated carrier is easy to cut and the handleability deteriorates.If the diameter is too large, the adsorption capacity is likely to be low because the substance to be adsorbed is unlikely to enter the inside of the coated carrier, so the cross-sectional area is converted to a circle. The diameter at this time is preferably 1 μm or more and 10 mm or less, more preferably 10 μm or more and 1 mm or less. Particularly preferably, it is 50 μm or more and 300 μm or less.

【0017】支持体材料 被覆担体の支持体に用いられる材料には、支持体自体の
安定性に優れ、溶出物がなく、乾燥・湿潤状態間の形状
変化も少なく、支持体表面へのリガンド固定が種々の方
法で容易且つ効率良く行なえるため、有機合成高分子材
料であることが好ましい。有機合成高分子材料は具体的
にはナイロン6、ナイロン66などのナイロン樹脂、ポ
リアセタール樹脂、ポリカーボネート樹脂、変性ポリフ
ェニレンオキシド樹脂、ポリブチレンテレフタレート、
ポリエチレンテレフタレート、ポリフェニレンスルファ
イド、ジアリルフタレート、ポリイミド、ポリアミドイ
ミド、ポリメチルペンテン、ホリスルフォン、ポリエー
テルスルフォン、ポリアクリレート、ポリエーテルエス
テルケトン、ポリテトラフルオロエチレン、ポリエチレ
ン、ポリプロピレン、ポリ塩化ビニル、ポリスチレン、
フェノール、エポキシ、ポリウレタン、ポリビニルアセ
タール、ビスコース、ABS、エチレンビニルアルコー
ル、ゴムユリア樹脂、セルロース、セルロースアセテー
ト、ポリメテルメタアクリレート等のいずれか或いはこ
れらを含む共重合体が挙げられる。これらの中で中実繊
維膜状への成型のしやすさや好ましい細孔の形成が容易
であること、更には柔軟性の点より、ポリエチレン、ポ
リプロピレン等のポリオレフィン、ポリスルフォン、ポ
リメチルメタアクレリート、セルロースを成分として含
む高分子材料がより好ましく、特にポリエチレン、ポリ
プロピレン等のポリオレフィン系の高分子材料が、短冊
状の貫通孔が得られ最も好ましい。
Support Material The material used for the support of the coated carrier is excellent in stability of the support itself, there is no eluate, there is little change in shape between dry and wet states, and ligand is immobilized on the surface of the support. Is preferably an organic synthetic polymer material because it can be easily and efficiently performed by various methods. Specific examples of the organic synthetic polymer material include nylon resins such as nylon 6 and nylon 66, polyacetal resins, polycarbonate resins, modified polyphenylene oxide resins, polybutylene terephthalate,
Polyethylene terephthalate, polyphenylene sulfide, diallyl phthalate, polyimide, polyamide imide, polymethyl pentene, holisulfone, polyether sulfone, polyacrylate, polyether ester ketone, polytetrafluoroethylene, polyethylene, polypropylene, polyvinyl chloride, polystyrene,
Examples include phenol, epoxy, polyurethane, polyvinyl acetal, viscose, ABS, ethylene vinyl alcohol, rubber urea resin, cellulose, cellulose acetate, polymer methacrylate, and copolymers containing these. Among these, polyolefins such as polyethylene and polypropylene, polysulfone, and polymethyl methacrylate are easy to form into a solid fiber membrane and easy to form preferable pores. Further, a polymer material containing cellulose as a component is more preferable, and a polyolefin polymer material such as polyethylene or polypropylene is most preferable since a rectangular through hole can be obtained.

【0018】製造方法 中実繊維膜状多孔質支持体の製造には、特有の温度で分
解して窒素ガス、炭酸ガス等を生じる有機、或いは無機
の発泡剤を用いる発泡剤分解法、蒸発型溶剤を原料段階
で添加混合し、合成時に溶剤を気散発泡させる溶剤気散
法、常態でガス状の発泡剤を機械的に混合気泡させる気
体混入法、重合過程で発生するガスを利用する化学反応
法、可溶性物質を高分子材料中に分散させた後に溶出す
る溶出法、粉末を溶融温度以下の燒結作用で粒子を互い
に結合させる燒結法、湿式相転換法、溶融相分離法、溶
融紡糸延伸開孔法などを用いることができる。この中で
好ましい繊維径の支持体が得やすいことより、湿式相転
換法、溶融相分離法、溶融紡糸延伸開孔法が好ましく、
特に中実繊維膜状の形状を容易に得られること、高分子
材料に溶剤その他の添加物を用いないため残留溶剤など
の問題がないことより、結晶性高分子を溶融紡糸して繊
維状に成形した後、冷延伸により結晶ラメラ間を開裂さ
せ、更に熱延伸により孔径を拡大させて得られるスタッ
クドラメラとミクロフィブリルとからなる多孔質構造を
形成させる延伸開孔法が特に好ましい。細孔がスタック
ドラメラとミクロフィブリルとからなる多孔質構造の
時、多孔質構造内への溶液の流れ抵抗が少なく、よって
中実繊維膜状多孔質支持体内部へのリガンド固定が内部
まで均質に行え、吸着材として内部まで有効に使用でき
るため特に好ましい。
Manufacturing Method In order to manufacture a solid fibrous membrane-like porous support, a foaming agent decomposition method using an organic or inorganic foaming agent that decomposes at a specific temperature to generate nitrogen gas, carbon dioxide gas, etc. Solvent diffusion method in which a solvent is added and mixed at the raw material stage and the solvent is diffused and foamed during synthesis, gas mixing method in which a gaseous foaming agent is mechanically mixed and bubbled in a normal state, chemistry using gas generated in the polymerization process Reaction method, dissolution method in which soluble substance is dispersed in polymer material and then eluted, sintering method in which powder is bonded to each other by sintering operation below melting temperature, wet phase inversion method, melt phase separation method, melt spinning and drawing An opening method or the like can be used. Among them, a support having a preferable fiber diameter is easily obtained, and a wet phase inversion method, a melt phase separation method, and a melt spinning and stretching method are preferable.
In particular, since a solid fiber membrane shape can be easily obtained, and there is no problem such as residual solvent because no solvent or other additives are used in the polymer material, the crystalline polymer is melt-spun into a fibrous shape. After molding, the stretch opening method is particularly preferred in which the crystal lamellas are cleaved by cold stretching and the porous structure composed of the stack dramella and microfibrils obtained by expanding the pore diameter by hot stretching is further formed. When the pores have a porous structure consisting of a stack dramella and microfibrils, the flow resistance of the solution into the porous structure is low, and the ligand is fixed uniformly inside the solid fibrous membrane porous support. It is particularly preferable because it can be effectively used as an adsorbent up to the inside.

【0019】リガンドの種類 被覆担体は、その被覆担体表面に或いは被覆層を介して
吸着目的物質との親和性を有する物質、即ちリガンドを
不溶化して使用できる。リガンドには吸着目的物質に対
して親和性を有する公知の合成物や、天然物質を使用で
きる。例えば抗低密度リポ蛋白質抗体、トリプトファ
ン、アセチルコリンレセプター由来ポリペプチド、フェ
ニルアラニン、シビレエイ由来ポリペプチド、血液型
(A型、B型)抗原、プロテインA、トリメチルアンモ
ニウム基、ジメチルアンモニウム基、アスパルテーム、
ポリミキシンB、抗免疫グロブリン抗体、抗CD8抗体
や抗CD4抗体等の抗白血球分化抗原抗体、抗癌壊死因
子抗体等の抗サイトカイン抗体、抗エンドトキシン抗
体、一本鎖或いは2本鎖DNA等である。更にこれらの
内、2種以上のリガンドが不溶化されていても良い。こ
れらのリガンドの分子量はいずれの分子量のものであっ
ても良いが、実用性の点より1,000,000以下が
利用しやすい。
Kinds of Ligands The coated carrier can be used after insolubilizing a substance having an affinity for the target substance to be adsorbed, that is, a ligand, on the surface of the coated carrier or via a coating layer. As the ligand, a known synthetic compound having an affinity for the target substance for adsorption or a natural substance can be used. For example, anti-low-density lipoprotein antibodies, tryptophan, polypeptides derived from acetylcholine receptor, phenylalanine, polypeptides derived from caviar rays, blood group (type A, type B) antigens, protein A, trimethyl ammonium group, dimethyl ammonium group, aspartame,
Examples include polymyxin B, anti-immunoglobulin antibody, anti-leukocyte differentiation antigen antibody such as anti-CD8 antibody and anti-CD4 antibody, anti-cytokine antibody such as anti-cancer necrosis factor antibody, anti-endotoxin antibody, single- or double-stranded DNA, and the like. Further, two or more of these ligands may be insolubilized. The molecular weight of these ligands may be any molecular weight, but from the viewpoint of practicality, 1,000,000 or less is easy to use.

【0020】リガンドの固定方法 リガンドを被覆担体に不溶化する方法には、多孔質支持
体表面にリガンドと親水性被覆層とを共存させる方法
や、あらかじめ形成した被覆担体表面に被覆層を介して
リガンドを不溶化する方法などがある。例えばリガンド
を溶解した液中に被覆担体を浸漬、或いは該液を噴霧す
ることによってコーティングする方法、化学的に或いは
放射線や電子線を用いてのグラフト法によって共有結合
する方法、或いは化学的方法により官能基を介して共有
結合する方法などがある。この中でグラフト法、官能基
を介しての共有結合法などリガンドを共有結合させるこ
とが使用時のリガンド溶出の危険性がなく、好ましい。
これらの中で、本発明者らの研究によれば、被覆層表面
にリガンドを共有結合させることが吸着能力が高く、製
造も容易であり、最も好ましい。
Ligand immobilization method The method of insolubilizing the ligand in the coated carrier includes a method in which the ligand and the hydrophilic coating layer coexist on the surface of the porous support, and a method in which the ligand is formed on the surface of the previously formed coated carrier via the coating layer. And the like. For example, a method of coating by dipping the coated carrier in a liquid in which a ligand is dissolved or spraying the liquid, a method of covalent bonding by a chemical or grafting method using radiation or an electron beam, or a chemical method There is a method of covalently bonding via a functional group. Among these, it is preferable to covalently bind the ligand, such as a grafting method or a covalent bonding method via a functional group, because there is no danger of elution of the ligand during use.
Among these, according to the study of the present inventors, it is most preferable that the ligand is covalently bonded to the surface of the coating layer because the adsorption ability is high and the production is easy.

【0021】担体活性化方法 被覆担体に官能基を得る方法の1例としてはハロゲン化
シアン法、エピクロルヒドリン法、エピブロムヒドリン
法、ビスエポキシド法、ブロモアセチルブロミド法、ト
レシルクロライド法、ブロモアセトアミド法等が知られ
ている。具体的にはアミノ基、カルボキシル基、ヒドロ
キシル基、チオール基、酸無水物基、サクシニルイミド
基、塩素基、アルデヒド基、アミド基、エポキシ基、ト
レシル基などがあげられる。この中で加熱滅菌時の安定
性よりエピクロルヒドリン法やエピブロムヒドリン法な
どで誘導されるエポキシ基が特に好ましい例としてあげ
られる。
Carrier activating method One example of a method for obtaining a functional group on the coated carrier is a cyanogen halide method, epichlorohydrin method, epibromohydrin method, bisepoxide method, bromoacetyl bromide method, tresyl chloride method, bromoacetamide method. The law is known. Specific examples include an amino group, a carboxyl group, a hydroxyl group, a thiol group, an acid anhydride group, a succinylimide group, a chlorine group, an aldehyde group, an amide group, an epoxy group, and a tresyl group. Among them, an epoxy group derived by an epichlorohydrin method, an epibromohydrin method, or the like is particularly preferable because of stability during heat sterilization.

【0022】リガンド固定量 導入するリガンドの量は特に規定は不要であるが、少な
すぎると吸着能力が低く、多過ぎると使用時にリガンド
が遊離する危険性が生じるため、被覆担体の細孔容積を
含む容積当たり1ng/ml以上100mg/ml以下
であることが良い。更に、あえてより好ましい範囲とし
ては1μg/ml以上100μg/ml以下があげられ
る。
The amount of immobilized ligand is not particularly limited. However, if the amount is too small, the adsorption capacity is low, and if the amount is too large, there is a risk that the ligand will be released during use. It is preferably from 1 ng / ml to 100 mg / ml per contained volume. Furthermore, a more preferable range is 1 μg / ml or more and 100 μg / ml or less.

【0023】用途 被覆担体の用途としては水或いは有機溶剤中の溶解物の
吸着が有り、特に血液などの体液中の蛋白質、糖、核
酸、ホルモン、脂質、サイトカイン等の吸着剤用支持体
として適する。最も好ましくは、臨床における体外循環
治療用選択的或いは特異的吸着剤の担体として使用でき
る。臨床における体外循環治療用選択的或いは特異的吸
着の用途としては、胆汁酸、アミロイド前駆蛋白A、癌
壊死因子、ビリルビン、ビリルビン結合アルブミン、エ
ンドトキシン、抗カルジオリピン抗体、抗アセチルコリ
ンレセプター抗体、低密度及び/または極低密度リポ蛋
白質、スルファチド付着性蛋白質、活性化補体成分、ア
ミロイド蛋白A、免疫複合体、抗血液型抗体、抗血小板
抗体、抗DNA抗体やリウマチ因子等の自己抗体及び/
または該自己抗体を生産する免疫B細胞、T細胞、免疫
グロブリンL鎖、血液凝固第VIII因子、血液凝固第
IX因子、β2 ミクログロブリン等があげられる。
Uses The coated carrier is used for the adsorption of dissolved substances in water or organic solvents, and is particularly suitable as a support for adsorbents such as proteins, sugars, nucleic acids, hormones, lipids and cytokines in body fluids such as blood. . Most preferably, it can be used as a carrier of a selective or specific adsorbent for treatment of extracorporeal circulation in clinical practice. Examples of the use of selective or specific adsorption for the treatment of extracorporeal circulation in the clinic include bile acids, amyloid precursor protein A, cancer necrosis factor, bilirubin, bilirubin-conjugated albumin, endotoxin, anti-cardiolipin antibodies, anti-acetylcholine receptor antibodies, low-density and / or Or autoantibodies such as very low density lipoprotein, sulfatide adhesion protein, activated complement component, amyloid protein A, immune complex, anti-blood group antibody, anti-platelet antibody, anti-DNA antibody and rheumatoid factor, and / or
Or immune B cells that produce the autoantibodies, T-cells, immunoglobulin L chain, blood coagulation factor VIII, blood coagulation factor IX, beta 2 microglobulin, and the like.

【0024】使用方法 被覆担体にリガンドを不溶化して得られた吸着材は、そ
のまま或いは短く切断し、或いは綿状にして、容器に充
填してカラムとして使用できる。或いは織布、不織布状
に加工した上記吸着材を、例えば該織布や不織布を重ね
て平板状にしたり円筒状に巻いて容器に充填して、カラ
ムとして使用できる。或いは被覆担体にリガンドを不溶
化して得られた吸着材の一部を接着剤等で容器に固定し
て使用することもできる。更に2種以上の吸着材が層状
に、或いはランダムに共存していても良い。容器は吸着
処理される溶液の流入口と流出口とを有し、吸着材が実
質的に流出しない構造で有れば良い。この時、容器の総
内容積に対する吸着材容積の割合は20%以上90%以
下の物が好ましく、より好ましい範囲をあえてあげると
40%以上80%以下が特に優れている。実際の使用に
当たっては血液を直接灌流しても良いし、あらかじめ遠
心分離法或いは膜法等によって分離して得た血漿を灌流
しても良い。この時血液または血漿は連続的に灌流して
も、或いは断続的に灌流しても良い。特に、本発明の被
覆担体にリガンドを不溶化して得られた吸着材は、繊維
を束状にして該束の両端をウレタンやシリコン接着剤等
を用いて束形状を保ち、該容器に固定されている時、血
小板の通過性に優れており、血液を直接灌流する目的に
好ましく使用できる。この時、束の容器への固定は該接
着剤によって成されていても良く、また容器構造を利用
した物理的な方法によって固定されていても良い。
Method of Use The adsorbent obtained by insolubilizing the ligand in the coated carrier can be used as a column as it is, cut into short pieces, or made into a cotton-like form, filled in a container, and used as a column. Alternatively, the adsorbent processed into a woven or nonwoven fabric can be used as a column by, for example, stacking the woven or nonwoven fabric into a flat plate or winding into a cylindrical shape and filling the container. Alternatively, a part of the adsorbent obtained by insolubilizing the ligand in the coated carrier may be used by fixing it to a container with an adhesive or the like. Further, two or more kinds of adsorbents may coexist in layers or randomly. The container may have an inlet and an outlet for the solution to be subjected to the adsorption treatment, and may have a structure in which the adsorbent does not substantially flow out. At this time, the ratio of the adsorbent volume to the total internal volume of the container is preferably 20% or more and 90% or less, and more preferably 40% or more and 80% or less in a more preferable range. In actual use, blood may be directly perfused, or plasma obtained by centrifugation or membrane separation in advance may be perfused. At this time, blood or plasma may be continuously perfused or intermittently perfused. In particular, the adsorbent obtained by insolubilizing the ligand in the coated carrier of the present invention, the fibers are bundled, and both ends of the bundle are kept in a bundle shape using urethane or silicone adhesive, and are fixed to the container. In this case, it has excellent platelet permeability and can be preferably used for the purpose of directly perfusing blood. At this time, the bundle may be fixed to the container by the adhesive, or may be fixed by a physical method using a container structure.

【0025】[0025]

【発明の効果】本発明の被覆担体は、脂質や蛋白質の非
特異吸着がなく血液などの体液との適合性に優れ、更に
多孔質体に均一な貫通孔をもつ中実繊維膜を使うため孔
内へも被吸着物質を含む体液は自由に出入りし内部孔面
積を有効に活用でき、同時に通液抵抗もなく操作出来る
と同時に多くのリガンドを容易に且つ安定に固定でき
る。
Industrial Applicability The coated carrier of the present invention uses a solid fiber membrane which has no nonspecific adsorption of lipids and proteins, has excellent compatibility with body fluids such as blood, and has a porous body having uniform through holes. The bodily fluid containing the substance to be adsorbed can freely enter and exit the pores, and the internal pore area can be effectively used. At the same time, the operation can be performed without liquid permeation resistance, and at the same time, many ligands can be easily and stably immobilized.

【実施例】【Example】

【0026】[0026]

【実施例1】高密度ポリエチレン(密度0.968、M
I値5.5、商品名ハイゼックス2208J)を紡口径
10mmの円形紡口を用いて、紡口温度150℃、ポリ
エチレン吐出量8g/分、紡糸距離5m、紡糸冷却温度
25℃、巻き取り張力3gf、巻き取り速度260m/
分、で溶融紡糸した。この時のドラフト比は7,000
であった。紡糸後115℃で2時間アニール処理した。
得られたポリエチレン糸を室温(24℃)にて、1次ロ
ーラー速度1.5m/分、2次ローラー速度2m/分で
冷延伸した。この時の冷延伸倍率は約1.3倍であっ
た。次に連続して108℃、119℃、122℃の3段
階の温度で、それぞれのローラー速度6m/分、7.8
m/分、8.7m/分の延伸速度で熱延伸して延伸開孔
し、中実繊維膜状多孔質構造のポリエチレン製の多孔質
支持体を得た。多孔質支持体の総延伸倍率は5.8倍、
糸径162μm、巻き取り長15kmであった。この多
孔質支持体を、エチレン含量30モル%のエチレン・ビ
ニルアルコールの共重合体をエタノール水溶液に1.0
重量%溶解した液に浸漬し、エチレン・ビニルアルコー
ル共重合体の親水性被覆層を有する被覆担体を得た。被
覆担体は水銀圧入法による平均孔径0.42μm、全細
孔容積4.4ml/g、空孔率80.0%、全表面積2
9.1m2 /g、孔径0.01μm以上10μm以下の
細孔の容積は全細孔容積の93%であった。次に被覆担
体(長さ10cmに切断、800本)を、ジメチルスル
ホキサイド5容、エピクロルヒドリン4容、10N水酸
化ナトリウム水溶液1容の混合液100ml中で、40
℃、2時間反応してエポキシ基を導入した。エポキシ基
を導入した被覆担体に0.1N水酸化ナトリウム水溶液
中でフェニルアラニンを反応させて、フェニルアラニン
固定吸着材を得た。フェニルアラニンの固定量は吸着体
1ml当たり71μ当量であった。フェニルアラニン固
定吸着材は、水銀圧入法による平均孔径0.22μm、
全細孔容積3.9ml/g、全表面積66.1m2
g、浸漬処理前後での重量変化より求めた被覆層の量
3.0×10-3g/m2 であった。非特異吸着性の測定
は、長さ10cmのフェニルアラニン固定吸着材200
本をリウマチ患者血漿6mlに浸漬して、振とう下で3
7℃、2時間反応させておこなった。リウマチ因子はR
Aテスト法にて測定した。各血漿成分の総量の反応前後
の減少率を吸着率として求めた。リウマチ因子、アルブ
ミン、IgG、トランスフェリン、総コレステロール、
フィブリノーゲン、カルシウムイオン、塩素イオンの各
吸着率はそれぞれ50.0%、2.6%、9.1%、
4.2%、1.7%、8.8%、0.3%、0%であ
り、吸着目的物質であるリウマチ因子に対しては高い吸
着性を示し、且つ他の血漿成分の非特異吸着は見られな
かった。
Example 1 High density polyethylene (density 0.968, M
I value 5.5, trade name Hyzex 2208J), using a circular spinner having a spinner diameter of 10 mm, spinning temperature 150 ° C., polyethylene discharge 8 g / min, spinning distance 5 m, spinning cooling temperature 25 ° C., winding tension 3 gf , Winding speed 260m /
Minutes, melt spinning. The draft ratio at this time is 7,000
Met. After spinning, annealing was performed at 115 ° C. for 2 hours.
The obtained polyethylene yarn was cold-drawn at room temperature (24 ° C.) at a primary roller speed of 1.5 m / min and a secondary roller speed of 2 m / min. The cold stretching ratio at this time was about 1.3 times. Next, at three successive temperatures of 108 ° C., 119 ° C. and 122 ° C., the respective roller speeds are 6 m / min and 7.8.
The film was stretched and opened by hot stretching at a stretching speed of 8.7 m / min at 8.7 m / min to obtain a porous support made of polyethylene having a solid fiber membrane-like porous structure. The total stretching ratio of the porous support is 5.8 times,
The yarn diameter was 162 μm and the winding length was 15 km. This porous support was prepared by adding an ethylene / vinyl alcohol copolymer having an ethylene content of 30 mol% to an aqueous ethanol solution for 1.0%.
It was immersed in a solution in which the weight percentage was dissolved to obtain a coated carrier having a hydrophilic coating layer of an ethylene / vinyl alcohol copolymer. The coated carrier has an average pore size of 0.42 μm by a mercury intrusion method, a total pore volume of 4.4 ml / g, a porosity of 80.0%, and a total surface area of 2
The volume of pores having a diameter of 9.1 m 2 / g and a pore size of 0.01 μm or more and 10 μm or less was 93% of the total pore volume. Next, the coated carrier (cut to a length of 10 cm, 800 pieces) is mixed with 40 ml of a mixture of 5 volumes of dimethyl sulfoxide, 4 volumes of epichlorohydrin, and 1 volume of 10 N aqueous sodium hydroxide solution.
The mixture was reacted at 2 ° C. for 2 hours to introduce an epoxy group. Phenylalanine was reacted with the coated carrier having the epoxy group introduced therein in a 0.1N aqueous sodium hydroxide solution to obtain a phenylalanine-fixed adsorbent. The fixed amount of phenylalanine was 71 μ equivalent per 1 ml of the adsorbent. The phenylalanine-fixed adsorbent has an average pore size of 0.22 μm by mercury intrusion method,
Total pore volume 3.9 ml / g, total surface area 66.1 m 2 /
g, the amount of the coating layer determined from the weight change before and after the immersion treatment was 3.0 × 10 −3 g / m 2 . The non-specific adsorption was measured using a 10 cm long phenylalanine-fixed adsorbent 200
Immerse the book in 6 ml of rheumatic patient plasma and shake
The reaction was performed at 7 ° C. for 2 hours. Rheumatoid factor is R
It was measured by the A test method. The rate of decrease in the total amount of each plasma component before and after the reaction was determined as the adsorption rate. Rheumatoid factor, albumin, IgG, transferrin, total cholesterol,
The respective adsorption rates of fibrinogen, calcium ion and chloride ion are 50.0%, 2.6%, 9.1%,
4.2%, 1.7%, 8.8%, 0.3%, and 0%, exhibit high adsorption to rheumatoid factor as an adsorption target substance, and are nonspecific for other plasma components No adsorption was seen.

【0027】[0027]

【実施例2】高密度ポリエチレン(密度0.968、M
I値5.5、商品名ハイゼックス2208J)を紡口径
35mmの円形紡口を用いて、紡口温度150℃、ポリ
エチレン吐出量16g/分、紡糸距離5m、紡糸冷却温
度24℃、巻き取り張力10gf、巻き取り速度400
m/分、で溶融紡糸した。この時のドラフト比は24,
000であった。紡糸後115℃で2時間アニール処理
した。得られたポリエチレン糸を室温(24℃)にて、
1次ローラー速度3.75m/分、2次ローラー速度5
m/分で冷延伸した。この時の冷延伸倍率は約1.3倍
であった。次に連続して108℃、119℃、122℃
の3段階の温度で、それぞれのローラー速度15m/
分、19.5m/分、21.8m/分の延伸速度で熱延
伸して延伸開孔し、中実繊維膜状多孔質構造のポリエチ
レン製の多孔質支持体を得た。多孔質支持体の総延伸倍
率は5.8倍、糸径176μm、巻き取り長15kmで
あった。この多孔質支持体を、ポリヒドロキシエチルメ
タクリレート(分子量約50,000)をメタノール水
溶液に1.0重量%溶解した液に浸漬し、ポリヒドロキ
シエチルメタクリレートの親水性被覆層を有する被覆担
体を得た。浸漬処理前後での重量変化より求めた被覆層
の量は1.8×10-3g/m2 であった。被覆担体(長
さ10cm、100本)を、ジエチルアミンを10%エ
タノール水溶液に30%濃度に溶解した液に浸漬して、
γ線を25kGy照射した。照射後十分に洗浄してジエ
チルアンモニウム基を表面に有する吸着材を得た。多孔
質支持体は水銀圧入法による平均孔径0.17μm、全
細孔容積3.3ml/g、空孔率77.0%、全表面積
49.1m2 /g、孔径0.01μm以上10μm以下
の細孔の容積は全細孔容積の88%であった。実施例1
と同様にして肝不全患者血漿を用いて非特異吸着性の測
定を行ったところ、総ビリルビン、アルブミン、Ig
G、トランスフェリン、総コレステロール、フィブリノ
ーゲン、カルシウムイオン、塩素イオンの各吸着率はそ
れぞれ62.4%、3.1%、3.3%、5.5%、
0.3%、4.7%、0.1%、06%であり、吸着目
的物質である総ビリルビンに対して高い吸着性を示し、
且つ他の血漿成分の非特異吸着は見られなかった。
Example 2 High density polyethylene (density 0.968, M
I value 5.5, trade name HIZEXX 2208J) using a circular spinner having a spinner diameter of 35 mm, spinning temperature 150 ° C., polyethylene discharge amount 16 g / min, spinning distance 5 m, spinning cooling temperature 24 ° C., winding tension 10 gf , Winding speed 400
m / min. The draft ratio at this time is 24,
000. After spinning, annealing was performed at 115 ° C. for 2 hours. At room temperature (24 ° C), the obtained polyethylene yarn is
Primary roller speed 3.75 m / min, secondary roller speed 5
Cold stretching was performed at m / min. The cold stretching ratio at this time was about 1.3 times. Then continuously 108 ° C, 119 ° C, 122 ° C
Roller speed of 15m /
, 19.5 m / min and 21.8 m / min, and stretched and opened to obtain a polyethylene porous support having a solid fiber membrane-like porous structure. The total stretching ratio of the porous support was 5.8 times, the yarn diameter was 176 μm, and the winding length was 15 km. This porous support was immersed in a solution in which polyhydroxyethyl methacrylate (molecular weight: about 50,000) was dissolved at 1.0% by weight in an aqueous methanol solution to obtain a coated carrier having a polyhydroxyethyl methacrylate hydrophilic coating layer. . The amount of the coating layer determined from the weight change before and after the immersion treatment was 1.8 × 10 −3 g / m 2 . The coated carrier (length: 10 cm, 100 pieces) is immersed in a solution of diethylamine dissolved in a 10% aqueous ethanol solution to a concentration of 30%,
Irradiated with 25 kGy of gamma rays. After the irradiation, the resultant was sufficiently washed to obtain an adsorbent having a diethylammonium group on the surface. The porous support has an average pore size of 0.17 μm, a total pore volume of 3.3 ml / g, a porosity of 77.0%, a total surface area of 49.1 m 2 / g, a pore size of 0.01 μm or more and 10 μm or less as determined by a mercury intrusion method. The pore volume was 88% of the total pore volume. Example 1
Non-specific adsorption was measured using plasma of a patient with hepatic failure in the same manner as described above. Total bilirubin, albumin, Ig
G, transferrin, total cholesterol, fibrinogen, calcium ion, and chloride ion adsorption rates were 62.4%, 3.1%, 3.3%, 5.5%, respectively.
0.3%, 4.7%, 0.1%, and 06%, showing high adsorptivity to total bilirubin as the target substance for adsorption,
In addition, nonspecific adsorption of other plasma components was not observed.

【0028】[0028]

【実施例3】実施例1の吸着材700本(充填率35
%)を、内径8mm、長さ10cmのポリカーボネート
製の円筒形の容器に、容器の長さ方向に吸着材を並べて
挿入し、吸着材両端部を容器と共にウレタンで接着固定
した。この時容器両端はウレタンで密閉された。容器に
は別に側面に入り口と出口を設けておいた。入り口と出
口は両端のウレタンで塞がれず、且つお互いに最も離れ
た位置に設けた。以上のようにして吸着器を得た。次に
得られた吸着器を用いて血液の直接灌流性について評価
した。抗凝固剤としてACD−A1/9容の存在下で健
常人血液を採取した。この血液40mlを吸着器に1.
2ml/分で灌流し、吸着器流出液中の血小板数を測定
したところ、血小板の減少率は9.7%と極僅かであ
り、優れた血小板通過性を示した。
Example 3 700 adsorbents of Example 1 (filling rate 35
%) Was inserted into a cylindrical container made of polycarbonate having an inner diameter of 8 mm and a length of 10 cm, in which the adsorbents were arranged in the longitudinal direction of the container, and both ends of the adsorbent were adhered and fixed together with the container with urethane. At this time, both ends of the container were sealed with urethane. The container had a separate entrance and exit on the side. The entrance and the exit were not blocked by urethane at both ends, and were provided at positions farthest from each other. An adsorber was obtained as described above. Next, direct perfusion of blood was evaluated using the obtained adsorber. Blood from a healthy subject was collected in the presence of ACD-A1 / 9 volume as an anticoagulant. 40 ml of this blood was placed in the adsorber for 1.
Perfusion was performed at 2 ml / min, and the platelet count in the adsorber effluent was measured. The platelet reduction rate was extremely small at 9.7%, indicating excellent platelet permeability.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) B01J 20/00 - 20/34 ──────────────────────────────────────────────────続 き Continued on front page (58) Field surveyed (Int.Cl. 7 , DB name) B01J 20/00-20/34

Claims (9)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 有機合成高分子材料からなる吸着材用の
中実繊維状多孔質担体の表面に高分子被覆層を有する
覆担体であって、該中実繊維状多孔質担体の細孔形状が
貫通孔であることを特徴とする被覆担体。
It is to 1. A surface of the actual fiber 維状 porous carrier in the adsorbent for made of an organic synthetic polymer material having a polymer coating layer
A coated carrier, wherein the pore shape of the solid fibrous porous carrier is
A coated carrier characterized by being a through hole .
【請求項2】 高分子被覆層がヒドロキシル基を有する
親水性合成化合物である請求項1記載の被覆担体。
2. The coated carrier according to claim 1, wherein the polymer coating layer is a hydrophilic synthetic compound having a hydroxyl group.
【請求項3】 高分子被覆層の量が10−5g/m
以上1g/m 以下である請求項2記載の被覆担体。
3. The amount of the polymer coating layer is 10 −5 g / m 2.
The coated carrier according to claim 2, which is not less than 1 g / m2.
【請求項4】 リガンド物質が親水性被覆層と共有結合
することで不溶化されている請求項1記載の被覆担体。
4. The coated carrier according to claim 1, wherein the ligand substance is insolubilized by covalently bonding to the hydrophilic coating layer.
【請求項5】 平均孔径が0.01μm以上10μm以
下の細孔を有する、有機合成高分子材料からなる吸着材
用の請求項1記載の被覆担体。
5. The coated carrier according to claim 1, which is for an adsorbent made of an organic synthetic polymer material and has fine pores having an average pore size of 0.01 μm or more and 10 μm or less.
【請求項6】 全表面積が1m /g以上500m
/g以下である請求項1記載の被覆担体。
6. The total surface area is 1 m 2 / g or more and 500 m 2.
2 / g or less.
【請求項7】 孔径0.01μm以上10μm以下の細
孔の容積が全細孔容積の40%以上である請求項1記載
の被覆担体。
7. The coated carrier according to claim 1, wherein the volume of pores having a pore size of 0.01 μm or more and 10 μm or less is 40% or more of the total pore volume.
【請求項8】 ポリオレフィンから成る請求項1記載の
被覆担体。
8. The coated carrier according to claim 1, comprising a polyolefin.
【請求項9】9. 有機合成高分子材料からなり細孔形状がPore shape made of organic synthetic polymer material
貫通孔である中実繊維状多孔質担体の表面に、ヒドロキHydroxy is added to the surface of the solid fibrous porous carrier that is a through hole.
シル基を有する親水性高分子被覆層を有し、該親水性被A hydrophilic polymer coating layer having a sil group;
覆層にリガンド物質が共有結合で不溶化されている被覆Coating in which the ligand substance is covalently insolubilized in the covering layer
担体が、繊維束状で容器に充填されて且つ容器に固定さThe carrier is filled into the container in the form of a fiber bundle and is fixed to the container.
れていることを特徴とする体外循環治療用吸着カラム。An adsorption column for extracorporeal circulation treatment, characterized in that it is used.
JP11426893A 1993-04-19 1993-04-19 Coated carrier Expired - Fee Related JP3353945B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11426893A JP3353945B2 (en) 1993-04-19 1993-04-19 Coated carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11426893A JP3353945B2 (en) 1993-04-19 1993-04-19 Coated carrier

Publications (2)

Publication Number Publication Date
JPH06296859A JPH06296859A (en) 1994-10-25
JP3353945B2 true JP3353945B2 (en) 2002-12-09

Family

ID=14633561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11426893A Expired - Fee Related JP3353945B2 (en) 1993-04-19 1993-04-19 Coated carrier

Country Status (1)

Country Link
JP (1) JP3353945B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009297229A (en) * 2008-06-12 2009-12-24 Nikkiso Co Ltd Hemocyte removal module
US8748560B2 (en) 2008-04-18 2014-06-10 Nikkiso Company, Ltd. Adsorbent for the removal of blood cells

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060089587A1 (en) * 2003-05-08 2006-04-27 Masaru Nakatani Low density lipoprotein/fibrinogen adsorbent and adsorption apparatus capable of whole blood treatment
JP5268250B2 (en) * 2006-12-05 2013-08-21 旭化成メディカル株式会社 Filter material, apparatus, and method for suppressing inflammatory cytokine production
JP6722908B2 (en) * 2016-04-18 2020-07-15 学校法人福岡大学 Protein adsorbent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8748560B2 (en) 2008-04-18 2014-06-10 Nikkiso Company, Ltd. Adsorbent for the removal of blood cells
JP2009297229A (en) * 2008-06-12 2009-12-24 Nikkiso Co Ltd Hemocyte removal module

Also Published As

Publication number Publication date
JPH06296859A (en) 1994-10-25

Similar Documents

Publication Publication Date Title
JP6243924B2 (en) Filter device combining beads and fibers
CN102317523B (en) Functionalized nonwoven article
US3983053A (en) Coated adsorbent materials
US6325939B2 (en) Surface modified polymer beads
CA2603073C (en) Absorbent and column for extracorporeal circulation
JP6922006B2 (en) How to purify biomolecules in a sample
EP0341413B1 (en) An adsorber module and adsorber apparatus for whole blood treatment
JP3353945B2 (en) Coated carrier
JP5784008B2 (en) Ligand immobilization substrate and method for producing the same
Jin et al. Surface modifying of microporous PTFE capillary for bilirubin removing from human plasma and its blood compatibility
JPH06296860A (en) Porous support and adsorption material
JP4997770B2 (en) Adsorber
WO2012068442A1 (en) High-surface area fibers and nonwoven membranes for use in bioseparations
JPH02119937A (en) Base membrane for affinity separation membrane and production thereof
JP5784132B2 (en) Ligand immobilization substrate and production method thereof, specific cell separation material, and blood treatment device
JP2814399B2 (en) Adsorber for whole blood processing
JP2777604B2 (en) Adsorbent for body fluid treatment
JPH01181875A (en) Adsorptive body of immune complex and removing device for immune complex with it
JP2010235496A (en) Immunoglobulin g separator
JPH08164202A (en) Liquid processing column and liquid processing method using this column
JP2023081326A (en) Blood purification carrier and blood purification column
JPS59177063A (en) Blood cleaning apparatus
JPS6379669A (en) Adsorbing material
JPH11165066A (en) Adsorption body for lipopolysaccharide, nucleic acid and microorganism
JPH10248927A (en) Adsorbent for purifying humor

Legal Events

Date Code Title Description
S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080927

Year of fee payment: 6

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090927

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090927

Year of fee payment: 7

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090927

Year of fee payment: 7

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100927

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110927

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees